VEGFA and hepatocellular carcinoma: Elevated PBLD expression may reduce HCC growth and invasion through inactivation of several tumorigenesis-related signaling pathways, including VEGF-A, ERK-MAPK, NF-κB, EMT and angiogenesis, thereby providing a potential therapeutic target for HCC (Supplementary Figure 5).